Aging is the main risk factor for Alzheimer’s disease. Dr. Nir Barzilai, Professor of Medicine and Genetics at the Albert Einstein College of Medicine and President of the Academy for Health and Lifespan Research, will discuss his efforts to develop methods to target the biology of aging, including through his “Targeting Aging with Metformin” (TAME) study, which aims to prove that a single drug can combat multiple diseases associated with aging and receive FDA approval for targeting aging.
“Tomorrow’s Breakthroughs Today” features world-class scientists discussing the path toward new, cutting-edge treatments for Alzheimer’s disease. Now in its fourth season and second at The Four Arts, this lecture series, founded in partnership with Heidi and Tom McWilliams, invites three top investigators to share the latest breaking updates on their research with moderator Dr. Howard Fillit, Co-Founder and Chief Science Officer of the Alzheimer’s Drug Discovery Foundation (ADDF). Founded in 1998 by Leonard A. and Ronald S. Lauder, the ADDF is dedicated to rapidly accelerating the development of novel therapeutics and biomarkers to prevent, treat, and cure Alzheimer’s disease and related dementias.
Presented by the Alzheimer’s Drug Discovery Foundation in partnership with Heidi and Tom McWilliams
